(Q36870079)

16 August 2017

1 reference

title

Environmental and dietary risk factors in Alzheimer's disease (English)

1 reference

16 August 2017

0 references

Remi Dosunmu

1

1 reference

16 August 2017

Jinfang Wu

series ordinal

2

1 reference

16 August 2017

Md Riyaz Basha

series ordinal

3

1 reference

16 August 2017

Nasser H Zawia

series ordinal

4

1 reference

16 August 2017

1 July 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

7

1 reference

16 August 2017

887-900

1 reference

Alzheimer Disease in the US Population

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The amyloid precursor protein gene: a neuropeptide gene with diverse functions in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Amyloid precursor protein mRNA levels in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Translating cell biology into therapeutic advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Molecular genetics of late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Alzheimer's disease in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Astrocytes: regulation of brain homeostasis via apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Fetal programming of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Metallothionein III is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Elevated cortical zinc in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Metals and amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

A molecular mechanism of aluminium-induced Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Laser microprobe analysis of brain aluminum in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Deficits in psychologic and classroom performance of children with elevated dentine lead levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Past adult lead exposure is linked to neurodegeneration measured by brain MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Neurofibrillary Changes Following Childhood Lead Encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lead-induced developmental perturbations in hippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence for Pb and Zn competition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Air pollutants and the respiratory system: toxicity and pharmacologic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Evidence that exposure of particulate air pollutants to human and rat alveolar macrophages leads to differential oxidative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Effect of ozone and aeroallergens on the respiratory health of asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Ultrafine particle deposition and clearance in the healthy and obstructed lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Do inhaled carbon nanoparticles translocate directly into the circulation in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Translocation and potential neurological effects of fine and ultrafine particles a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Translocation of Inhaled Ultrafine Particles to the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The expression and function of chemokines involved in CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Parkinson's disease and brain levels of organochlorine pesticides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Neurodegenerative diseases and exposure to pesticides in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Behavioral and neurochemical changes associated with chronic exposure to low-level concentration of pesticide mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Invited review: Anticholinesterases: dramatic aspects of their use and misuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Effects of physostigmine and lecithin on memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Caloric intake and the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Association of diabetes mellitus and dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Vitamin B12, folate, homocysteine and dementia: are they really related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Elevated levels of homocysteine compromise blood-brain barrier integrity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-β (Aβ) 40 or Aβ 42 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Alzheimer disease beta-amyloid activity mimics cholesterol oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Brain cholesterol: long secret life behind a barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Lipid metabolism in cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Is the LDL receptor-related protein involved in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Micronutrients and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Mediterranean diet, Alzheimer disease, and vascular mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.7.887

21 January 2018

Identifiers

DOI

10.1586/14737175.7.7.887

1 reference

16 August 2017

1 reference